Dashboard
Manage Tickers

ADMA ADMA BIOLOGICS, INC.

Nasdaq admabiologics.com


$ 15.00 $ 0.74 (5.06 %)    

Wednesday, 05-Nov-2025 17:32:17 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 622.38 $ 4.94 (0.8 %)
DIA $ 473.04 $ 2.23 (0.47 %)
SPY $ 677.28 $ 2.47 (0.37 %)
TLT $ 89.01 $ -0.57 (-0.64 %)
GLD $ 365.20 $ 0.10 (0.03 %)
$ 15.37
$ 14.50
$ 14.75 x 300
$ 16.05 x 100
$ 14.42 - $ 15.65
$ 13.50 - $ 25.67
6,301,680
na
nm
$ 0.49
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 03-18-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-23-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-24-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-25-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 03-13-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 03-13-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-10-2018 06-30-2018 10-Q
31 05-14-2018 03-31-2018 10-Q
32 03-29-2018 12-31-2017 10-K
33 11-03-2017 09-30-2017 10-Q
34 08-11-2017 06-30-2017 10-Q
35 05-12-2017 03-31-2017 10-Q
36 02-24-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-12-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-23-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

update-adma-biologics-q3-adj-eps-016-beats-015-estimate-sales-134224m-beat-130533m-estimate
UPDATE: ADMA Biologics Q3 Adj. EPS $0.16 B...
11/05/2025 23:18:28

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.15 ...

adma-biologics-fy2026--revenue-expected-to-be-at-least-630000m-vs-637727m-est
ADMA Biologics FY2026 Revenue expected to...
11/05/2025 21:18:06

ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $630.000M vs $637.727M Est

adma-biologics-fy2025--revenue-expected-to-be-at-least-510000m-vs-506202m-est
ADMA Biologics FY2025 Revenue expected to...
11/05/2025 21:14:15

ADMA Biologics (NASDAQ:ADMA) FY2025 Revenue expected to be more than $510.000M vs $506.202M Est

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

adma-biologics-option-alert-nov-21-15-calls-sweep-8-near-the-ask-2000--1076-vs-372-oi-earnings-116-after-close-est-ref14225
ADMA Biologics Option Alert: Nov 21 $15 Ca...
10/08/2025 17:18:22

redwire-posts-downbeat-q2-results-joins-tandem-diabetes-care-fortinet-symbotic-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Redwire Posts Downbeat Q2 Results, Joins T...
08/07/2025 12:14:08

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 12:07:31

why-groupon-shares-are-trading-higher-by-around-28-here-are-20-stocks-moving-premarket
Why Groupon Shares Are Trading Higher By A...
08/07/2025 09:41:13

adma-biologics-sees-fy2026-sales-500000m-625000m-vs-64117m-est
ADMA Biologics Sees FY2026 Sales $500.000M...
08/06/2025 20:43:18

ADMA Biologics (NASDAQ:ADMA) sees FY2026 sales of $500.000 million-$625.000 million vs $641.17 million analyst estimate.

adma-biologics-sees-fy2025-sales-500000m-625000m-vs-50767m-est
ADMA Biologics Sees FY2025 Sales $500.000M...
08/06/2025 20:43:08

ADMA Biologics (NASDAQ:ADMA) sees FY2025 sales of $500.000 million-$625.000 million vs $507.67 million analyst estimate.

adma-biologics-q2-adj-eps-014-inline-sales-12198m-miss-12267m-estimate
ADMA Biologics Q2 Adj. EPS $0.14, Inline, ...
08/06/2025 20:07:37

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

is-adma-biologics-gaining-or-losing-market-support
Is ADMA Biologics Gaining or Losing Market...
08/01/2025 13:00:25

is-adma-biologics-gaining-or-losing-market-support
Is ADMA Biologics Gaining or Losing Market...
07/02/2025 18:00:33

how-is-the-market-feeling-about-adma-biologics
How Is The Market Feeling About ADMA Biolo...
06/04/2025 16:00:37

raymond-james-maintains-strong-buy-on-adma-biologics-raises-price-target-to-32
Raymond James Maintains Strong Buy on ADMA...
05/08/2025 17:26:36

Raymond James analyst Elliot Wilbur maintains ADMA Biologics (NASDAQ:ADMA) with a Strong Buy and raises the price target fro...

crude-oil-gains-over-2-us-foods-posts-downbeat-earnings
Crude Oil Gains Over 2%; US Foods Posts Do...
05/08/2025 16:46:42

adma-biologics-fy2026--revenue-expected-to-be-more-than-62500m-vs-62923m-est
ADMA Biologics FY2026 Revenue expected to...
05/07/2025 20:16:02

ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $625.00M vs $629.23M Est

adma-biologics-fy2025--revenue-expected-to-be-more-than-50000m-vs-49510m-est
ADMA Biologics FY2025 Revenue expected to...
05/07/2025 20:15:49

ADMA Biologics (NASDAQ:ADMA) FY2025 Revenue expected to be more than $500.00M vs $495.10M Est

adma-biologics-q1-adj-eps-014-misses-016-estimate-sales-11480m-miss-11640m-estimate
ADMA Biologics Q1 Adj. EPS $0.14 Misses $0...
05/07/2025 20:15:00

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.1...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION